Lysophosphatidylcholine

Lysophosphatidylcholine is a lipid of Glycerophospholipids (GP) class. Lysophosphatidylcholine is associated with abnormalities such as Ischemia, Obesity, Diabetes Mellitus, Non-Insulin-Dependent, Fatty Liver and Atherosclerosis. The involved functions are known as Inflammation, antagonists, Signal Transduction, Signal Pathways and Saturated. Lysophosphatidylcholine often locates in Body tissue, Head, integral to membrane, Membrane and Extracellular. The associated genes with Lysophosphatidylcholine are RHOA gene, Homologous Gene, GPR4 gene, GPR68 gene and TRPV2 gene. The related lipids are Nonesterified Fatty Acids, lysophosphatidylethanolamine, Lysophosphatidylcholines, Phosphatidylserines and 25-hydroxycholesterol. The related experimental models are Knock-out and Disease model.

References related to lipids published in Others

PMID	Journal	Published Date	Author	Title
23686350	Pharmacol. Rev.	2013	Davenport AP et al.	International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands.
21995961	Am. J. Physiol. Gastrointest. Liver Physiol.	2012	Kakisaka K et al.	Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis.
16020521	Am. J. Physiol. Regul. Integr. Comp. Physiol.	2005	Tappia PS et al.	Phospholipid profile of developing heart of rats exposed to low-protein diet in pregnancy.
26514602	Biochim. Biophys. Acta	2016	Mitchell NJ et al.	Branched phospholipids render lipid vesicles more susceptible to membrane-active peptides.
28445851	J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.	2017	Suárez-García S et al.	Development and validation of a UHPLC-ESI-MS/MS method for the simultaneous quantification of mammal lysophosphatidylcholines and lysophosphatidylethanolamines in serum.
27591807	Biochim. Biophys. Acta	2016	Skočaj M et al.	Characterisation of plasmalemmal shedding of vesicles induced by the cholesterol/sphingomyelin binding protein, ostreolysin A-mCherry.
27544588	Bioorg. Med. Chem.	2016	Ragle LE et al.	Discovery and synthetic optimization of a novel scaffold for hydrophobic tunnel-targeted autotaxin inhibition.
27178174	Biochim. Biophys. Acta	2016	Subbaiah PV et al.	Enhanced incorporation of dietary DHA into lymph phospholipids by altering its molecular carrier.
27161639	Antimicrob. Agents Chemother.	2016	Parra Millán R et al.	Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models.
26858457	Proc. Natl. Acad. Sci. U.S.A.	2016	Chaudhuri P et al.	Membrane translocation of TRPC6 channels and endothelial migration are regulated by calmodulin and PI3 kinase activation.
26764184	Gastroenterology	2016	Hirsova P et al.	Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
26431570	Curr. Top. Dev. Biol.	2015	Fogarty CE and Bergmann A	The Sound of Silence: Signaling by Apoptotic Cells.
25307302	Clin. Biochem.	2015	Haynes CA and De Jesús VR	The stability of hexacosanoyl lysophosphatidylcholine in dried-blood spot quality control materials for X-linked adrenoleukodystrophy newborn screening.
24982116	Circulation	2014	Thiele JR et al.	Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy.
24672027	J. Virol.	2014	Ciechonska M and Duncan R	Lysophosphatidylcholine reversibly arrests pore expansion during syncytium formation mediated by diverse viral fusogens.
24373610	Prostaglandins Leukot. Essent. Fatty Acids	2014 Feb-Mar	Abdolahi A et al.	The effects of aspirin and fish oil consumption on lysophosphatidylcholines and lysophosphatidic acids and their correlates with platelet aggregation in adults with diabetes mellitus.
24268529	Mol. Genet. Metab.	2014	Theda C et al.	Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasible.
23929934	Diabetes	2013	La Torre D et al.	Decreased cord-blood phospholipids in young age-at-onset type 1 diabetes.
23514731	Diabetes Care	2013	Lehmann R et al.	Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver.
22853859	Surgery	2013	Machado-Aranda D et al.	Increased phospholipase A2 and lyso-phosphatidylcholine levels are associated with surfactant dysfunction in lung contusion injury in mice.
22641094	J. Hepatol.	2012	Kakisaka K et al.	A hedgehog survival pathway in 'undead' lipotoxic hepatocytes.
22492530	Diabetes	2012	Renner S et al.	Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced β-cell mass.
21123073	Bioorg. Med. Chem.	2011	Choi J et al.	An efficient synthesis of γ-hydroxy-α,β-unsaturated aldehydic esters of 2-lysophosphatidylcholine.
20833923	J. Exp. Biol.	2010	Silva-Cardoso L et al.	Paralytic activity of lysophosphatidylcholine from saliva of the waterbug Belostoma anurum.
20083230	Biochim. Biophys. Acta	2010	Sparkes BL et al.	Intestinal lipid alterations occur prior to antibody-induced prostaglandin E2 production in a mouse model of ischemia/reperfusion.
19608987	Circ. Res.	2009	Filep JG	Platelets affect the structure and function of C-reactive protein.
19520972	Circ. Res.	2009	Eisenhardt SU et al.	Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques.
19383550	Prostaglandins Other Lipid Mediat.	2009	Kabarowski JH	G2A and LPC: regulatory functions in immunity.
19282326	J. Endocrinol.	2009	Lan H et al.	GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis.
19091635	J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.	2009	Albert CJ et al.	Chromatographic methods for the analyses of 2-halofatty aldehydes and chlorohydrin molecular species of lysophosphatidylcholine.
18356547	Stroke	2008	Mannheim D et al.	Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques.
18070590	Biochim. Biophys. Acta	2008	Alves M et al.	Effect of lysophosphatidylcholine on the surface hydration of phospholipid vesicles.
17505011	Clin. Cancer Res.	2007	Maurer BJ et al.	Improved oral delivery of N-(4-hydroxyphenyl)retinamide with a novel LYM-X-SORB organized lipid complex.
17105874	Mol. Pharmacol.	2007	Faustino RS et al.	RanGAP-mediated nuclear protein import in vascular smooth muscle cells is augmented by lysophosphatidylcholine.
17055038	Thromb. Res.	2007	Beckett CS et al.	Phospholipase A2-catalyzed hydrolysis of plasmalogen phospholipids in thrombin-stimulated human platelets.
16002999	Am. J. Physiol. Lung Cell Mol. Physiol.	2005	Mehta D	Lysophosphatidylcholine: an enigmatic lysolipid.
15755840	Am. J. Clin. Nutr.	2005	Chen AH et al.	Phosphatidylcholine and lysophosphatidylcholine excretion is increased in children with cystic fibrosis and is associated with plasma homocysteine, S-adenosylhomocysteine, and S-adenosylmethionine.
15728718	Mol. Biol. Cell	2005	Wang L et al.	Lysophosphatidylcholine-induced surface redistribution regulates signaling of the murine G protein-coupled receptor G2A.
15125832	Mol. Cell	2004	Lauber K et al.	Clearance of apoptotic cells: getting rid of the corpses.
14681556	Proc. Natl. Acad. Sci. U.S.A.	2004	Radu CG et al.	T cell chemotaxis to lysophosphatidylcholine through the G2A receptor.
12809603	Cell	2003	Lauber K et al.	Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal.
12473560	Circulation	2002	Terasawa K et al.	Nonselective cation currents regulate membrane potential of rabbit coronary arterial cell: modulation by lysophosphatidylcholine.
12446479	Clin. Chem.	2002	Liebisch G et al.	High-throughput quantification of lysophosphatidylcholine by electrospray ionization tandem mass spectrometry.
12379686	Infect. Immun.	2002	Flieger A et al.	Characterization of the gene encoding the major secreted lysophospholipase A of Legionella pneumophila and its role in detoxification of lysophosphatidylcholine.
11696481	Circulation	2001	Shah PK et al.	Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I.
11694619	J. Nutr.	2001	Sugawara T et al.	Lysophosphatidylcholine enhances carotenoid uptake from mixed micelles by Caco-2 human intestinal cells.
11532104	Kidney Int.	2001	Vuong TD et al.	Albumin restores lysophosphatidylcholine-induced inhibition of vasodilation in rat aorta.
10884372	Circ. Res.	2000	Jing Q et al.	Lysophosphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis.
10712548	Plant Physiol.	2000	Mongrand S et al.	Import of lyso-phosphatidylcholine into chloroplasts likely at the origin of eukaryotic plastidial lipids.
10504482	Kidney Int.	1999	Heermeier K et al.	Oxidative stress mediates apoptosis induced by oxidized low-density lipoprotein and oxidized lipoprotein(a).
9545198	Curr. Biol.	1998	van Dijk MC et al.	Exogenous phospholipase D generates lysophosphatidic acid and activates Ras, Rho and Ca2+ signaling pathways.
9370252	Biochim. Biophys. Acta	1997	Razinkov VI et al.	New fluorescent lysolipids: preparation and selective labeling of inner liposome leaflet.
7236208	Biochem. J.	1980	Arthur G and Sheltawy A	The presence of lysophosphatidylcholine in chromaffin granules.
4328399	Blood	1971	Shohet SB et al.	Hereditary hemolytic anemia associated with abnormal membrane lipids: mechanism of accumulation of phosphatidyl choline.